Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Molecular Partners Ag (MOLN) Shares Outstanding: 2021-2025

  • Molecular Partners Ag's Shares Outstanding rose 1079.65% to $3.6 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $3.6 billion, marking a year-over-year increase of 1079.65%. This contributed to the annual value of $314.1 million for FY2023, which is 7.27% up from last year.
  • Per Molecular Partners Ag's latest filing, its Shares Outstanding stood at $3.6 billion for Q2 2025, which was up 1,079.65% from $305.4 million recorded in Q2 2024.
  • Over the past 5 years, Molecular Partners Ag's Shares Outstanding peaked at $3.6 billion during Q2 2025, and registered a low of $1.1 million during Q2 2022.
  • In the last 3 years, Molecular Partners Ag's Shares Outstanding had a median value of $311.7 million in 2023 and averaged $1.1 billion.
  • Its Shares Outstanding has fluctuated over the past 5 years, first fell by 15.33% in 2022, then surged by 15,263.79% in 2024.
  • Molecular Partners Ag's Shares Outstanding (Quarterly) stood at $345.8 million in 2021, then declined by 15.33% to $292.8 million in 2022, then increased by 8.61% to $318.0 million in 2023, then soared by 15,263.79% to $305.4 million in 2024, then spiked by 1,079.65% to $3.6 billion in 2025.
  • Its last three reported values are $3.6 billion in Q2 2025, $305.4 million for Q2 2024, and $318.0 million during Q4 2023.